Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 27, 2012Expert Opinion on Therapeutic Patents

Shikonin and its derivatives: a patent review

View Full Paper
Ask AI
Bookmark
Share

Authors

RWRubing WangTianjin UniversityRYRunting YinJiangsu UniversityWZWen ZhouJingzhou Central Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2012) studied this question.

synapsesocial.com/papers/6a91adb8cd6b16172ebe4968https://doi.org/10.1517/13543776.2012.709237
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Naturally Occurring Isohexenylnaphthazarin Pigments: A New Class of Drugs1980 · 99 citations
  2. 2Total synthesis of shikalkin [(±)-shikonin]1983 · 23 citations
  3. 3During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain2008 · 166 citations
  4. 4Matrix Metalloproteinases1999 · 3,922 citations